Have a personal or library account? Click to login
Synergism of PDL/PD1 and IL33/ST2 Axis in Tumor Immunology Cover

Synergism of PDL/PD1 and IL33/ST2 Axis in Tumor Immunology

EABR. Experimental and Applied Biomedical Research
Volume 20 (2019): Issue 3 (September 2019)
By: Marina Jovanovic,  Nevena Gajovic,  Miodrag L. Lukic,  Ana Popovic and  Ivan Jovanovic  
Open Access
|Nov 2019

Authors

Marina Jovanovic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia

Nevena Gajovic

gajovicnevena@yahoo.com

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia

Miodrag L. Lukic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia

Ana Popovic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia

Ivan Jovanovic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia
DOI: https://doi.org/10.2478/sjecr-2018-0033 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 223 - 228
Submitted on: Aug 31, 2018
Accepted on: Sep 4, 2018
Published on: Nov 7, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
IL-33,
PD-1,
tumor,
antitumor immunity
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2019 Marina Jovanovic, Nevena Gajovic, Miodrag L. Lukic, Ana Popovic, Ivan Jovanovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 20 (2019): Issue 3 (September 2019)Next article